Haemonetics Corp (HAE): Cost of Revenue
$546.44M
Year ended 2026-03-28
$553.87M
Trailing 12 months to 2026-06-27
-0.4%
3-year compound annual growth
+2.9%
5-year compound annual growth
+0.8%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-28 | $546.44M | -10.7% | 2026-05-20, From 2025-03-30 |
| 2025-03-29 | $611.87M | -0.9% | 2026-05-20, From 2024-03-31 |
| 2024-03-30 | $617.51M | +11.6% | 2026-05-20, From 2023-04-02 |
| 2023-04-01 | $553.56M | +13.5% | 2025-05-21, From 2022-04-03 |
| 2022-04-02 | $487.69M | +3.2% | 2024-05-20, From 2021-04-04 |
| 2021-04-03 | $472.62M | -6.2% | 2023-05-22, From 2020-03-29 |
| 2020-03-28 | $503.97M | -8.4% | 2022-05-25, From 2019-03-31 |
| 2019-03-30 | $550.04M | +11.8% | 2021-05-26, From 2018-04-01 |
| 2018-03-31 | $492.01M | -3.1% | 2020-05-20, From 2017-04-02 |
| 2017-04-01 | $507.62M | +0.9% | 2019-05-22, From 2016-04-03 |
| 2016-04-02 | $502.92M | +5.7% | 2018-05-23, From 2015-03-29 |
| 2015-03-28 | $475.95M | +1.2% | 2017-05-24, From 2014-03-30 |
| 2014-03-29 | $470.14M | +1.4% | 2016-06-01, From 2013-03-31 |
| 2013-03-30 | $463.86M | +29.4% | 2015-05-22, From 2012-04-01 |
| 2012-03-31 | $358.60M | +11.5% | 2014-05-22, From 2011-04-03 |
| 2011-04-02 | $321.49M | +4.4% | 2013-05-20, From 2010-04-04 |
| 2010-04-03 | $307.95M | +6.3% | 2012-05-22, From 2009-03-29 |
| 2009-03-28 | $289.71M | n/a | 2011-05-26, From 2008-03-30 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Haemonetics Corp (HAE) | 2026-03-28 | $546.44M | -10.7% |
| Penumbra Inc (PEN) | 2025-12-31 | $461.23M | +4.9% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $777.64M | +9.0% |
| Integra Lifesciences Holdings Corp (IART) | 2025-12-31 | $803.62M | +10.3% |
| Embecta Corp. (EMBC) | 2025-09-30 | $403.60M | +4.0% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $468.72M | +4.0% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
| Teleflex Inc (TFX) | 2025-12-31 | $871.96M | +31.7% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $256.30M | +1.1% |
Compare HAE, PEN, MMSI, IART side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗